Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[A step-by-step guide for safe off-label prescribing]Tjitske M van der Zanden, Lenneke Schrier, Saskia N de Wildt
British Journal of Clinical Pharmacology|February 16, 2026
Beyond the label: Rethinking off-label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapyTjitske M van der Zanden, Miriam G Mooij, Matthijs de Hoog, et al.
Archives of Disease in Childhood|November 2, 2016
Developing a paediatric drug formulary for the NetherlandsTjitske M van der Zanden, Saskia N de Wildt, Yves Liem, et al.
British Journal of Clinical Pharmacology|May 9, 2023
Guiding future paediatric drug studies based on existing pharmacokinetic and efficacy data: Cardiovascular drugs as a proof of conceptNori J L Smeets, Lieke P M Raaijmakers, Tjitske M van der Zanden, et al.
Paediatric Drugs|March 28, 2022
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric FormularyJolien J M Freriksen, Tjitske M van der Zanden, Inge G A Holsappel, et al.
Neonatology|January 16, 2023
Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project)Marika A de Hoop-Sommen, Tjitske M van der Zanden, Karel Allegaert, et al.
Paediatric Drugs|March 15, 2020
Does a Dose Calculator as an Add-On to a Web-Based Paediatric Formulary Reduce Calculation Errors in Paediatric Dosing? A Non-Randomized Controlled StudyTjitske M van der Zanden, Matthijs de Hoog, Jonathan D Windster, et al.
Clinical Pharmacology and Therapeutics|April 23, 2020
Chloroquine Dosing Recommendations for Pediatric COVID-19 Supported by Modeling and SimulationLaurens F M Verscheijden, Tjitske M van der Zanden, Lianne P M van Bussel, et al.
Frontiers in Pharmacology|January 4, 2021
A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of ConceptStan J F Hartman, Joost G E Swaving, Stijn W van Beek, et al.
Clinical Pharmacology and Therapeutics|June 19, 2021
Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo FrameworkTjitske M van der Zanden, Miriam G Mooij, Nienke J Vet, et al.
Pageof 2